O'Dell Group’s Edwards Lifesciences EW Stock Holding History

O'Dell Group’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-444	Closed	-$33.9K	–	205
2023 Q4	$33.9K	Buy	+444	New	+$30.9K	0.01%	246
2023 Q3	–	Sell	-444	Closed	-$41.9K	–	190
2023 Q2	$41.9K	Buy	+444	New	+$38.6K	0.01%	210
2022 Q4	–	Sell	-444	Closed	-$37K	–	173
2022 Q3	$37K	Hold	444	–	–	0.01%	167
2022 Q2	$42K	Hold	444	–	–	0.01%	164
2022 Q1	$52K	Buy	444 +390	+722%	+$43.8K	0.02%	168
2021 Q4	$7K	Hold	54	–	–	﹤0.01%	340
2021 Q3	$6K	Buy	+54	New	+$6.16K	﹤0.01%	351

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

O'Dell Group's EW Position: Q1 2024 in Review

O'Dell Group sold out of Edwards Lifesciences (EW) in Q1 2024, closing a stake of 444 shares — an estimated $33.9K sold.

O'Dell Group first reported a position in EW in Q3 2021 and held it in 7 quarters. The position peaked at $52K in Q1 2022. 1,281 funds tracked by Wall St. Rank hold EW as of Q1 2024.

O'Dell Group reported no remaining Edwards Lifesciences position as of Q1 2024 after selling out during the quarter.
O'Dell Group sold 444 Edwards Lifesciences shares in Q1 2024, an estimated $33.9K.
O'Dell Group first reported a position in Edwards Lifesciences in Q3 2021 and held it in 7 quarters.
O'Dell Group's Edwards Lifesciences position peaked at $52K in Q1 2022.
1,281 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2024.

Based on O'Dell Group's 13F filing for Q1 2024, filed 7 May 2024.